{"disease":{"id":"adenovirus-infection","name":"adenovirus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT06392451","title":"LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"DiaSorin Molecular LLC","has_results":false},{"nct_id":"NCT05305040","title":"Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":451,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT07152600","title":"Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":262,"lead_sponsor_name":"Qingyuan Zhan","has_results":false},{"nct_id":"NCT07387367","title":"A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"SymBio Pharmaceuticals","has_results":false},{"nct_id":"NCT03159364","title":"Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT07225972","title":"Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":69,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT05179057","title":"Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":57,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT03475212","title":"Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Pediatric Transplantation & Cellular Therapy Consortium","has_results":false},{"nct_id":"NCT04706923","title":"A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"SymBio Pharmaceuticals","has_results":false},{"nct_id":"NCT05101213","title":"Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04693637","title":"Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT06027879","title":"Anti-viral T-cell Therapy by Gamma Capture","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":25,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT04364178","title":"Viral Specific T-Lymphocytes to Treat Adenovirus or CMV","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Jessie L. Alexander","has_results":false},{"nct_id":"NCT06909110","title":"Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Jessie L. Alexander","has_results":false},{"nct_id":"NCT04722029","title":"Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT02702427","title":"Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"St. Anna Kinderkrebsforschung","has_results":false},{"nct_id":"NCT07104591","title":"TETRAVI Expanded Access Program","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}